Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMRN |
---|---|---|
09:32 ET | 42191 | 74.49 |
09:34 ET | 200 | 74.295 |
09:36 ET | 2032 | 74.305 |
09:38 ET | 2743 | 74.67 |
09:39 ET | 2139 | 74.52 |
09:41 ET | 3203 | 74.6075 |
09:43 ET | 1326 | 74.8 |
09:45 ET | 1200 | 74.835 |
09:48 ET | 2344 | 74.8 |
09:50 ET | 2426 | 74.775 |
09:52 ET | 6876 | 75.07 |
09:54 ET | 3265 | 75.2 |
09:56 ET | 5026 | 75.2982 |
09:57 ET | 2231 | 75.125 |
09:59 ET | 1400 | 74.98 |
10:01 ET | 900 | 75 |
10:03 ET | 2227 | 74.91 |
10:06 ET | 1646 | 74.86 |
10:08 ET | 2520 | 74.8797 |
10:10 ET | 1200 | 74.8325 |
10:12 ET | 1591 | 74.73 |
10:14 ET | 3082 | 74.61 |
10:15 ET | 1106 | 74.64 |
10:17 ET | 600 | 74.7 |
10:19 ET | 2627 | 74.78 |
10:24 ET | 800 | 74.8 |
10:26 ET | 881 | 74.72 |
10:28 ET | 2328 | 74.8 |
10:30 ET | 1887 | 74.7 |
10:32 ET | 964 | 74.68 |
10:33 ET | 836 | 74.735 |
10:35 ET | 1808 | 74.71 |
10:37 ET | 800 | 74.65 |
10:39 ET | 840 | 74.73 |
10:42 ET | 100 | 74.69 |
10:44 ET | 2001 | 74.63 |
10:46 ET | 100 | 74.6 |
10:48 ET | 519 | 74.565 |
10:50 ET | 1000 | 74.52 |
10:51 ET | 1700 | 74.54 |
10:53 ET | 2310 | 74.57 |
10:55 ET | 531 | 74.56 |
10:57 ET | 1370 | 74.55 |
11:00 ET | 1200 | 74.55 |
11:02 ET | 1265 | 74.53 |
11:04 ET | 300 | 74.48 |
11:06 ET | 506 | 74.485 |
11:08 ET | 300 | 74.46 |
11:09 ET | 1420 | 74.39 |
11:11 ET | 1625 | 74.435 |
11:13 ET | 1114 | 74.45 |
11:15 ET | 300 | 74.38 |
11:18 ET | 1320 | 74.235 |
11:20 ET | 1416 | 74.24 |
11:24 ET | 3710 | 74.34 |
11:26 ET | 800 | 74.31 |
11:29 ET | 1561 | 74.34 |
11:31 ET | 400 | 74.335 |
11:33 ET | 4367 | 74.35 |
11:36 ET | 700 | 74.265 |
11:38 ET | 1300 | 74.215 |
11:40 ET | 400 | 74.22 |
11:42 ET | 100 | 74.22 |
11:44 ET | 1523 | 74.25 |
11:45 ET | 5044 | 74.28 |
11:47 ET | 1418 | 74.34 |
11:49 ET | 1110 | 74.365 |
11:51 ET | 1035 | 74.33 |
11:54 ET | 2231 | 74.37 |
11:56 ET | 5062 | 74.54 |
11:58 ET | 100 | 74.56 |
12:00 ET | 735 | 74.55 |
12:02 ET | 1800 | 74.525 |
12:03 ET | 1000 | 74.55 |
12:05 ET | 933 | 74.55 |
12:07 ET | 608 | 74.53 |
12:09 ET | 1728 | 74.57 |
12:12 ET | 1158 | 74.64 |
12:14 ET | 4651 | 74.54 |
12:16 ET | 851 | 74.53 |
12:18 ET | 2465 | 74.6092 |
12:20 ET | 811 | 74.66 |
12:21 ET | 871 | 74.63 |
12:23 ET | 7768 | 74.89 |
12:25 ET | 3574 | 74.835 |
12:27 ET | 1327 | 74.86 |
12:30 ET | 800 | 74.81 |
12:32 ET | 1237 | 74.74 |
12:34 ET | 500 | 74.75 |
12:36 ET | 300 | 74.755 |
12:38 ET | 2786 | 74.74 |
12:39 ET | 400 | 74.735 |
12:41 ET | 1100 | 74.745 |
12:43 ET | 1694 | 74.66 |
12:45 ET | 604 | 74.67 |
12:48 ET | 300 | 74.69 |
12:50 ET | 2600 | 74.715 |
12:52 ET | 3015 | 74.61 |
12:54 ET | 1000 | 74.65 |
12:56 ET | 200 | 74.665 |
12:57 ET | 200 | 74.67 |
12:59 ET | 800 | 74.67 |
01:01 ET | 4802 | 74.69 |
01:03 ET | 1708 | 74.67 |
01:06 ET | 10492 | 74.54 |
01:08 ET | 1200 | 74.535 |
01:10 ET | 1333 | 74.505 |
01:12 ET | 1300 | 74.52 |
01:14 ET | 2274 | 74.56 |
01:15 ET | 3018 | 74.39 |
01:17 ET | 591 | 74.4118 |
01:19 ET | 783 | 74.435 |
01:21 ET | 300 | 74.45 |
01:24 ET | 700 | 74.44 |
01:26 ET | 537 | 74.44 |
01:28 ET | 7549 | 74.3848 |
01:30 ET | 1000 | 74.31 |
01:32 ET | 344 | 74.3445 |
01:33 ET | 657 | 74.325 |
01:35 ET | 10269 | 74.44 |
01:37 ET | 1400 | 74.37 |
01:39 ET | 400 | 74.325 |
01:42 ET | 400 | 74.33 |
01:44 ET | 2661 | 74.3 |
01:46 ET | 1019 | 74.3 |
01:48 ET | 1600 | 74.2871 |
01:50 ET | 600 | 74.29 |
01:51 ET | 2749 | 74.28 |
01:53 ET | 3296 | 74.315 |
01:55 ET | 2839 | 74.255 |
01:57 ET | 2435 | 74.26 |
02:00 ET | 5264 | 74.275 |
02:02 ET | 435 | 74.25 |
02:04 ET | 892 | 74.25 |
02:06 ET | 4392 | 74.28 |
02:08 ET | 4910 | 74.265 |
02:09 ET | 8200 | 74.28 |
02:11 ET | 15251 | 74.24 |
02:13 ET | 600 | 74.25 |
02:15 ET | 668 | 74.25 |
02:18 ET | 63240 | 74.345 |
02:20 ET | 2100 | 74.35 |
02:22 ET | 1200 | 74.44 |
02:24 ET | 600 | 74.435 |
02:26 ET | 9737 | 74.43 |
02:27 ET | 1020 | 74.41 |
02:29 ET | 1100 | 74.475 |
02:31 ET | 1518 | 74.44 |
02:33 ET | 1710 | 74.4 |
02:36 ET | 905 | 74.345 |
02:38 ET | 31123 | 74.48 |
02:40 ET | 1647 | 74.48 |
02:42 ET | 1236 | 74.5 |
02:44 ET | 2319 | 74.5 |
02:45 ET | 2981 | 74.46 |
02:47 ET | 676 | 74.45 |
02:49 ET | 3820 | 74.48 |
02:51 ET | 2521 | 74.49 |
02:54 ET | 1900 | 74.5 |
02:56 ET | 1600 | 74.61 |
02:58 ET | 1400 | 74.645 |
03:00 ET | 2771 | 74.615 |
03:02 ET | 2180 | 74.56 |
03:03 ET | 2415 | 74.62 |
03:05 ET | 3077 | 74.64 |
03:07 ET | 1346 | 74.64 |
03:09 ET | 5200 | 74.55 |
03:12 ET | 2253 | 74.54 |
03:14 ET | 2538 | 74.5 |
03:16 ET | 3817 | 74.475 |
03:18 ET | 2614 | 74.51 |
03:20 ET | 3688 | 74.525 |
03:21 ET | 4716 | 74.5 |
03:23 ET | 2700 | 74.63 |
03:25 ET | 3231 | 74.62 |
03:27 ET | 2372 | 74.67 |
03:30 ET | 2041 | 74.675 |
03:32 ET | 2900 | 74.74 |
03:34 ET | 900 | 74.755 |
03:36 ET | 7023 | 74.78 |
03:38 ET | 4942 | 74.81 |
03:39 ET | 2400 | 74.835 |
03:41 ET | 5862 | 74.93 |
03:43 ET | 2904 | 74.975 |
03:45 ET | 10502 | 74.98 |
03:48 ET | 4428 | 75.01 |
03:50 ET | 5102 | 75.005 |
03:52 ET | 12344 | 75 |
03:54 ET | 8964 | 75.01 |
03:56 ET | 12520 | 74.955 |
03:57 ET | 16445 | 75.07 |
03:59 ET | 1042392 | 75.07 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomarin Pharmaceutical Inc | 14.3B | 71.1x | --- |
Beigene Ltd | 16.0B | -19.7x | --- |
United Therapeutics Corp | 12.2B | 13.0x | +8.22% |
Neurocrine Biosciences Inc | 13.6B | 37.2x | +62.04% |
Medpace Holdings Inc | 12.0B | 39.4x | +35.10% |
Exact Sciences Corp | 8.4B | -34.3x | --- |
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.3B |
---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 189.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.31 |
EPS | $1.06 |
Book Value | $26.25 |
P/E Ratio | 71.1x |
Price/Sales (TTM) | 5.8 |
Price/Cash Flow (TTM) | 45.9x |
Operating Margin | 7.09% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.